耐受性-话题@MedSci

#耐受性#

144篇内容 | 4036人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417697, encodeId=9e53141e697d1, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=神经内分泌肿瘤的治疗：EBTATE在早期研究中显示出良好耐受性和有效性, objectType=article, longId=172180, objectId=d4771e218083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4771e218083, replyNumber=0, likeNumber=62, createdTime=2019-06-27, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4771e218083, moduleTitle=神经内分泌肿瘤的治疗：EBTATE在早期研究中显示出良好耐受性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4771e218083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417696, encodeId=73bb141e6969e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Arthritis Rheumatol ：Fasinumab治疗骨关节炎痛的疗效、耐受性和关节安全性, objectType=article, longId=170146, objectId=36861e01468a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36861e01468a, replyNumber=0, likeNumber=67, createdTime=2019-06-27, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36861e01468a, moduleTitle=Arthritis Rheumatol ：Fasinumab治疗骨关节炎痛的疗效、耐受性和关节安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36861e01468a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417695, encodeId=8be3141e6950a, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=PNAS：肠道微生物组影响吗啡耐受性, objectType=article, longId=168794, objectId=fd36168e948d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd36168e948d, replyNumber=0, likeNumber=79, createdTime=2019-06-21, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd36168e948d, moduleTitle=PNAS：肠道微生物组影响吗啡耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd36168e948d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417694, encodeId=89a6141e69488, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后, objectType=article, longId=168059, objectId=552b1680597c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552b1680597c, replyNumber=0, likeNumber=66, createdTime=2019-06-12, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552b1680597c, moduleTitle=2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=552b1680597c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417693, encodeId=a4c8141e69328, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：沙利度胺类似物活性及耐受性的影响因素, objectType=article, longId=165316, objectId=2246165316e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2246165316e0, replyNumber=0, likeNumber=103, createdTime=2019-05-05, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2246165316e0, moduleTitle=Blood：沙利度胺类似物活性及耐受性的影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2246165316e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417692, encodeId=73bf141e692ee, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, objectType=article, longId=159655, objectId=7e6a15965554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6a15965554, replyNumber=0, likeNumber=72, createdTime=2019-02-10, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6a15965554, moduleTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e6a15965554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417691, encodeId=548a141e6915b, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Arthritis Rheumatol：奥马珠单抗治疗系统性红斑狼疮的安全性和耐受性（STOP LUPUS）, objectType=article, longId=157058, objectId=913315e05859, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=913315e05859, replyNumber=0, likeNumber=52, createdTime=2019-01-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=913315e05859, moduleTitle=Arthritis Rheumatol：奥马珠单抗治疗系统性红斑狼疮的安全性和耐受性（STOP LUPUS）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=913315e05859)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417690, encodeId=acef141e69030, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JAMA ONCOL：胃肠道间质瘤患者接受5年伊马替尼辅助治疗的有效性和耐受性, objectType=article, longId=153285, objectId=571b15328544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=571b15328544, replyNumber=0, likeNumber=73, createdTime=2018-11-13, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=571b15328544, moduleTitle=JAMA ONCOL：胃肠道间质瘤患者接受5年伊马替尼辅助治疗的有效性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=571b15328544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417689, encodeId=4f20141e689ff, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Immunotherapy：马齿苋库提取物舌下免疫治疗耐受性和阳性治疗效果研究, objectType=article, longId=152633, objectId=232f15263330, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=232f15263330, replyNumber=0, likeNumber=60, createdTime=2018-11-04, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=232f15263330, moduleTitle=Immunotherapy：马齿苋库提取物舌下免疫治疗耐受性和阳性治疗效果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=232f15263330)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417688, encodeId=b13d141e6889e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性, objectType=article, longId=150028, objectId=fb3e1500282b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3e1500282b, replyNumber=0, likeNumber=58, createdTime=2018-10-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3e1500282b, moduleTitle=ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb3e1500282b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417687, encodeId=6284141e68726, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Blood：Mcl-1转基因小鼠模型可用于**预测MCL-1抑制剂临床应用的疗效和耐受性, objectType=article, longId=147425, objectId=65f614e4258f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65f614e4258f, replyNumber=0, likeNumber=61, createdTime=2018-08-27, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65f614e4258f, moduleTitle=Blood：Mcl-1转基因小鼠模型可用于**预测MCL-1抑制剂临床应用的疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65f614e4258f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417686, encodeId=f701141e6860b, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Sci Signal：科学家发现止痛新方法有望降低药物耐受性和上瘾风险, objectType=article, longId=147240, objectId=bb4414e240d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb4414e240d4, replyNumber=0, likeNumber=49, createdTime=2018-08-24, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb4414e240d4, moduleTitle=Sci Signal：科学家发现止痛新方法有望降低药物耐受性和上瘾风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb4414e240d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417685, encodeId=8446141e68501, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, objectType=article, longId=147185, objectId=72b714e1854b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72b714e1854b, replyNumber=0, likeNumber=56, createdTime=2018-08-23, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72b714e1854b, moduleTitle=J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72b714e1854b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417684, encodeId=1659141e684c0, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, objectType=article, longId=145876, objectId=88e41458e6ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88e41458e6ed, replyNumber=0, likeNumber=78, createdTime=2018-08-06, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88e41458e6ed, moduleTitle=lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88e41458e6ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417683, encodeId=c432141e68310, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=J Periodontal Res: ：牙周膜细胞在牙龈卟啉单胞菌脂多糖刺激下内毒素耐受性的变化, objectType=article, longId=145007, objectId=d39114500e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d39114500e9b, replyNumber=0, likeNumber=34, createdTime=2018-07-24, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d39114500e9b, moduleTitle=J Periodontal Res: ：牙周膜细胞在牙龈卟啉单胞菌脂多糖刺激下内毒素耐受性的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d39114500e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417682, encodeId=b7f0141e682cb, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？, objectType=article, longId=144790, objectId=024b144e90ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=024b144e90ed, replyNumber=0, likeNumber=73, createdTime=2018-07-21, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=024b144e90ed, moduleTitle=Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=024b144e90ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417681, encodeId=12e7141e681a2, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=iScience：科学家阐明癌症药物耐受性发生的分子奥秘, objectType=article, longId=142410, objectId=6d8d14241022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d8d14241022, replyNumber=0, likeNumber=55, createdTime=2018-07-05, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d8d14241022, moduleTitle=iScience：科学家阐明癌症药物耐受性发生的分子奥秘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d8d14241022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417680, encodeId=fa47141e6807f, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——**部分：新发癫痫的治疗, objectType=article, longId=141830, objectId=a8bb141830d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8bb141830d8, replyNumber=0, likeNumber=28, createdTime=2018-06-29, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8bb141830d8, moduleTitle=2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——**部分：新发癫痫的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8bb141830d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417679, encodeId=1146141e67964, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——第二部分：治性癫痫的治疗, objectType=article, longId=141829, objectId=bd8a14182942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8a14182942, replyNumber=0, likeNumber=30, createdTime=2018-06-29, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8a14182942, moduleTitle=2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——第二部分：治性癫痫的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd8a14182942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417678, encodeId=144c141e678da, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet Gastroenterol Hepatol：用生物类似物替代英夫利昔治疗炎性肠病的耐受性良好, objectType=article, longId=133871, objectId=4c981338e17f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c981338e17f, replyNumber=0, likeNumber=58, createdTime=2018-04-01, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c981338e17f, moduleTitle=Lancet Gastroenterol Hepatol：用生物类似物替代英夫利昔治疗炎性肠病的耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c981338e17f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐受性

2020-05-29

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

神经内分泌肿瘤的治疗：EBTATE在早期研究中显示出良好耐受性和有效性

2019-06-27

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Arthritis Rheumatol ：Fasinumab治疗骨关节炎痛的疗效、耐受性和关节安全性

2019-06-27

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

PNAS：肠道微生物组影响吗啡耐受性

2019-06-21

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后

2019-06-12

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood：沙利度胺类似物活性及耐受性的影响因素

2019-05-05

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期

2019-02-10

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Arthritis Rheumatol：奥马珠单抗治疗系统性红斑狼疮的安全性和耐受性（STOP LUPUS）

2019-01-01

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

JAMA ONCOL：胃肠道间质瘤患者接受5年伊马替尼辅助治疗的有效性和耐受性

2018-11-13

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Immunotherapy：马齿苋库提取物舌下免疫治疗耐受性和阳性治疗效果研究

2018-11-04

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性

2018-10-01

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Blood：Mcl-1转基因小鼠模型可用于**预测MCL-1抑制剂临床应用的疗效和耐受性

2018-08-27

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Sci Signal：科学家发现止痛新方法有望降低药物耐受性和上瘾风险

2018-08-24

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J Viral Hepat：全剂量的sofobuvir联合NS5A抑制剂是治疗严重肾功能不全的HCV患者的一种良好的耐受性和有效的治疗方法

2018-08-23

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

lancet oncol：阿帕替尼联合依托泊苷用于铂类耐受性/难治性乳腺癌的效果和安全性

2018-08-06

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

J Periodontal Res: ：牙周膜细胞在牙龈卟啉单胞菌脂多糖刺激下内毒素耐受性的变化

2018-07-24

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Am J Hematol：来那度胺+MEC治疗复发/难治AML患者的耐受性如何？

2018-07-21

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

iScience：科学家阐明癌症药物耐受性发生的分子奥秘

2018-07-05

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——**部分：新发癫痫的治疗

2018-06-29

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

2018 AAN/AES实践指南：新型抗癫痫药的疗效和耐受性——第二部分：治性癫痫的治疗

2018-06-29

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet Gastroenterol Hepatol：用生物类似物替代英夫利昔治疗炎性肠病的耐受性良好

2018-04-01

科室
- - 订阅+
  - 更多科室
工具
服务